the decrease in early stage dollars... I wonder if this is because there are less early stage deals, or that the value of each early deal has gotten lower.
Yea... the numbers are pretty interesting. I wonder if the figures are just US based or for VCs across the globe. I figure the bio tech industry will keep getting more and more of the VC attention as the green wave rolls on.
